JP3645906B2
(ja)
*
|
1993-11-19 |
2005-05-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
TW487572B
(en)
*
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
WO1999006563A1
(en)
|
1997-07-30 |
1999-02-11 |
Emory University |
Novel bone mineralization proteins, dna, vectors, expression systems
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US6194006B1
(en)
*
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
EP1611881A1
(en)
*
|
1999-03-31 |
2006-01-04 |
Janssen Pharmaceutica N.V. |
Pregelatinized starch in a controlled release formulation
|
EP1044683A1
(en)
*
|
1999-04-15 |
2000-10-18 |
Debio Recherche Pharmaceutique S.A. |
One-step dispersion method for the microencapsulation of water soluble substances
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
US7030097B1
(en)
|
1999-07-14 |
2006-04-18 |
Cornell Research Foundation, Inc. |
Controlled nucleic acid delivery systems
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
ES2162746B1
(es)
*
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
US6705757B2
(en)
*
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
*
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US7838037B2
(en)
*
|
1999-11-17 |
2010-11-23 |
Tagra Biotechnologies Ltd. |
Method of microencapsulation
|
GB2356386A
(en)
|
1999-11-17 |
2001-05-23 |
Tagra Biotechnologies Ltd |
Microencapsulation
|
DE60119696T2
(de)
|
2000-03-15 |
2007-01-25 |
Wolfgang Ross Sadee |
Naloxon- und naltrexon-analoga in der behandlung bei drogenmissbrauch
|
GB0008411D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Vectura Ltd |
Pharmaceutical preparations and their manufacture
|
US6992065B2
(en)
|
2000-04-19 |
2006-01-31 |
Genentech, Inc. |
Sustained release formulations
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
AU2001284982A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Method of forming microparticles
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
CA2424892A1
(en)
*
|
2000-10-06 |
2002-04-11 |
Jagotec Ag |
Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
JP2004534721A
(ja)
*
|
2000-10-31 |
2004-11-18 |
ピーアール ファーマシューティカルズ,インク. |
生理活性分子の向上した送達のための方法及び組成物
|
AU2002235253A8
(en)
|
2000-12-21 |
2005-10-06 |
Inhale Therapeutic Syst |
Induced phase transition method for the production of microparticles containing hydrophilic active agents
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
WO2002058671A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Debio Recherche Pharmaceutique S.A. |
Burst free pharmaceutical microparticules
|
CA2439120C
(en)
*
|
2001-02-23 |
2011-07-05 |
Genentech, Inc. |
Erodible polymers for injection
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
ES2554106T3
(es)
*
|
2001-06-21 |
2015-12-16 |
Genentech, Inc. |
Formulación de liberación sostenida
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
WO2003002100A1
(en)
*
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Tamper-proof narcotic delivery system
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
AU2002337692B2
(en)
|
2001-09-26 |
2007-09-13 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
AU2002346960A1
(en)
|
2001-10-06 |
2003-04-22 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
SE0201599D0
(sv)
*
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
CN1668276A
(zh)
*
|
2002-07-31 |
2005-09-14 |
阿尔萨公司 |
可注射的储库组合物及其用途
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
WO2004064752A2
(en)
*
|
2003-01-22 |
2004-08-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
US6908484B2
(en)
*
|
2003-03-06 |
2005-06-21 |
Spinecore, Inc. |
Cervical disc replacement
|
US20060286138A1
(en)
*
|
2003-04-10 |
2006-12-21 |
Malshe Vinod C |
Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
BRPI0409032A
(pt)
|
2003-04-10 |
2006-05-02 |
Pr Pharmaceuticals |
método para a produção de micropartìculas à base de emulsão
|
WO2004108115A1
(ja)
*
|
2003-06-03 |
2004-12-16 |
Santen Pharmaceutical Co., Ltd. |
微粒子の製造法
|
EP1628664A4
(en)
*
|
2003-06-04 |
2008-11-05 |
Alkermes Inc |
POLYMORPHIC FORMS OF NALTREXONE
|
CA2819769C
(en)
|
2003-07-18 |
2016-06-28 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
CA2533592C
(en)
|
2003-07-23 |
2015-11-10 |
Pr Pharmaceuticals, Inc. |
Controlled release compositions
|
US6987111B2
(en)
*
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
WO2005015160A2
(en)
*
|
2003-08-07 |
2005-02-17 |
The Children's Hospital Of Philadelphia |
Functionalized polymeric colloids
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
EP2633853A1
(en)
*
|
2004-01-12 |
2013-09-04 |
The Trustees of The University of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
AU2006269927B2
(en)
*
|
2004-01-12 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
JP2007517912A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
心脈管および腎臓の適応症のための制御放出cgrp送達組成物
|
EP1703915A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods of using cgrp for cardiovascular and renal indications
|
CA2552758A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
|
US20050245461A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
US20050245541A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
EP2409707B8
(en)
*
|
2004-04-15 |
2015-05-06 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US7919499B2
(en)
*
|
2004-04-22 |
2011-04-05 |
Alkermes, Inc. |
Naltrexone long acting formulations and methods of use
|
US20050260272A1
(en)
*
|
2004-05-05 |
2005-11-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
EP1679065A1
(en)
*
|
2005-01-07 |
2006-07-12 |
OctoPlus Sciences B.V. |
Controlled release compositions for interferon based on PEGT/PBT block copolymers
|
WO2006078841A1
(en)
*
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles
|
EP1838305A1
(en)
*
|
2005-01-21 |
2007-10-03 |
Richard H. Matthews |
Radiosensitizer formulations comprising nitrohistidine derivatives
|
US8598092B2
(en)
|
2005-02-02 |
2013-12-03 |
Halliburton Energy Services, Inc. |
Methods of preparing degradable materials and methods of use in subterranean formations
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
EP1962586B1
(en)
*
|
2005-12-22 |
2017-07-12 |
Oakwood Laboratories L.L.C. |
Sublimable sustained release delivery system and method of making same
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
EP2012803A4
(en)
*
|
2006-04-20 |
2012-08-01 |
Univ Utah Res Found |
POLYMER COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
|
KR100781604B1
(ko)
*
|
2006-06-13 |
2007-12-03 |
한불화장품주식회사 |
다가 알코올을 이용한 난용성 활성 성분 함유 중공형 다중마이크로캡슐의 제조 방법 및 이를 함유하는 화장료 조성물
|
WO2008021133A2
(en)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
WO2008026894A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Sk Chemicals Co., Ltd. |
Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
|
US20090263346A1
(en)
*
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
JP2010511713A
(ja)
*
|
2006-12-05 |
2010-04-15 |
ランデック コーポレイション |
薬物送達
|
CN101636480B
(zh)
|
2007-01-11 |
2014-04-09 |
诺维信公司 |
包含活性化合物的颗粒
|
CA2680365A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
CN101801415B
(zh)
|
2007-05-25 |
2015-09-23 |
Rb医药品有限公司 |
利培酮化合物的持续递送制剂
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
EP2214672B1
(en)
|
2007-10-18 |
2012-10-17 |
Aiko Biotechnology |
Combination analgesic employing opioid and neutral antagonist
|
EP2222281B1
(en)
*
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
WO2009109993A1
(en)
*
|
2008-02-04 |
2009-09-11 |
Torrent Pharmaceuticals Ltd. |
Extended release dosage form of paliperidone
|
CA2714506C
(en)
*
|
2008-02-08 |
2016-06-07 |
Qps Llc |
Composition for sustained release delivery of proteins or peptides
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
EA021422B1
(ru)
*
|
2008-06-16 |
2015-06-30 |
Бинд Терапьютикс, Инк. |
Полимерные наночастицы, содержащие терапевтическое средство, и способ их получения
|
EA020753B1
(ru)
|
2008-06-16 |
2015-01-30 |
Бинд Терапьютикс, Инк. |
Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
US20100087337A1
(en)
*
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
WO2010030868A1
(en)
*
|
2008-09-11 |
2010-03-18 |
Surmodics Pharmaceuticals, Inc. |
Solvent extraction microencapsulation with tunable extraction rates
|
CA2737484C
(en)
*
|
2008-09-18 |
2017-10-10 |
Surmodics Pharmaceuticals, Inc. |
Microencapsulation process with solvent and salt
|
JP5588993B2
(ja)
*
|
2008-11-14 |
2014-09-10 |
イファ ユニバーシティ−インダストリー コラボレーション ファウンデーション |
高分子微粒球の製造方法及びその方法により製造された高分子微粒球
|
US20100143479A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Oakwood Laboratories, Llc |
Method of making sustained release microparticles
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
US20100216804A1
(en)
|
2008-12-15 |
2010-08-26 |
Zale Stephen E |
Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
|
ES2319158B1
(es)
*
|
2008-12-23 |
2010-01-26 |
Grifols, S.A |
Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa.
|
CA2749993C
(en)
*
|
2009-01-23 |
2016-12-20 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
US20100196436A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Gooberman Lance L |
Implants containing disulfiram and an anti-inflammatory agent
|
US8791093B2
(en)
*
|
2009-05-29 |
2014-07-29 |
Lance L. Gooberman |
Pharmaceutical delivery systems for treatment of substance abuse and other addictions
|
CN104323981B
(zh)
|
2009-09-28 |
2019-03-12 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
US8641900B2
(en)
*
|
2009-11-05 |
2014-02-04 |
Taiwan Biotech Co., Ltd |
Method and device for continuously preparing microspheres, and collection unit thereof
|
BR112012016021A8
(pt)
|
2009-12-11 |
2018-06-12 |
Bind Biosciences Inc |
Formulações estáveis para liofilização de partículas terapêuticas
|
EA201290499A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Композиции терапевтических полимерных наночастиц с высокой температурой стеклования и высокомолекулярными сополимерами
|
WO2011119262A1
(en)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
CA2798710C
(en)
|
2010-05-11 |
2019-08-27 |
Venkat R. Garigapati |
Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
|
GB2481017B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
KR20120011344A
(ko)
*
|
2010-07-21 |
2012-02-08 |
에스케이케미칼주식회사 |
고분자 미립구의 제조방법 및 그 방법에 의해 제조된 고분자 미립구
|
AU2011308897B2
(en)
*
|
2010-09-30 |
2015-06-18 |
Evonik Corporation |
Emulsion method for preparing low residual solvent microparticles
|
US20120082731A1
(en)
*
|
2010-09-30 |
2012-04-05 |
Adrian Raiche |
Method For Removing Residual Organic Solvent From Microparticles
|
US9023897B2
(en)
*
|
2010-12-29 |
2015-05-05 |
Medincell |
Biodegradable drug delivery compositions
|
US8546521B2
(en)
|
2011-01-28 |
2013-10-01 |
Cerulean Pharma Inc. |
Method for fabricating nanoparticles
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2012158527A2
(en)
|
2011-05-13 |
2012-11-22 |
Howmedica Osteonics |
Organophosphorous & multivalent metal compound compositions & methods
|
KR101481859B1
(ko)
*
|
2011-05-20 |
2015-01-14 |
에스케이케미칼주식회사 |
초기 약물 방출이 감소된 고분자 미립자의 제조방법 및 그 방법에 의해 제조된 고분자 미립자
|
KR101265955B1
(ko)
|
2011-09-07 |
2013-05-22 |
한불화장품주식회사 |
혼합 생약 추출발효물을 배합시킨 마이크로캡슐을 포함하는 화장료 조성물
|
BR112015005940A2
(pt)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
processo para a preparação de nanopartículas terapêuticas
|
CN103834054B
(zh)
*
|
2012-11-27 |
2018-05-11 |
东丽先端材料研究开发(中国)有限公司 |
聚乳酸中空微球的制备方法
|
FI3010962T4
(fi)
*
|
2013-06-20 |
2023-05-04 |
|
Sigmoidaalisen vapautumisprofiilin omaavien polylaktidi-polyglykolidimikrohiukkasten valmistus
|
EP3010962B2
(en)
|
2013-06-20 |
2023-02-08 |
Pharmathen S.A. |
Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile
|
JP2016527308A
(ja)
|
2013-08-06 |
2016-09-08 |
ドン クック ファーマシューティカル カンパニー リミテッド |
エンテカビル微小球及びこれを含む非経口投与用医薬組成物
|
EP3076951B1
(en)
*
|
2013-12-05 |
2020-09-30 |
Celal Albayrak |
Process for the production of drug formulations for oral administration
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
JP6348616B2
(ja)
|
2014-03-14 |
2018-06-27 |
ファイザー・インク |
治療剤を含む治療用ナノ粒子ならびにその製造および使用方法
|
US9439864B2
(en)
*
|
2014-07-07 |
2016-09-13 |
Antriabio, Inc. |
Solvent extraction from biodegradable microparticles
|
KR101738127B1
(ko)
*
|
2014-08-08 |
2017-05-22 |
(주)비씨월드제약 |
약물 함유 서방성 미립자의 제조 방법
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
ES2808150T3
(es)
|
2014-11-07 |
2021-02-25 |
Indivior Uk Ltd |
Regímenes de dosificación de buprenorfina
|
WO2016196851A2
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US11154510B2
(en)
|
2015-06-11 |
2021-10-26 |
Alrise Biosystems Gmbh |
Process for the preparation of drug loaded microparticles
|
AU2016355236C1
(en)
|
2015-11-16 |
2022-09-22 |
Medincell |
A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
|
MX2018014016A
(es)
|
2016-05-16 |
2019-08-01 |
Intarcia Therapeutics Inc |
Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
WO2018178973A1
(en)
|
2017-03-26 |
2018-10-04 |
Mapi Pharma Ltd. |
Glatiramer depot systems for treating progressive forms of multiple sclerosis
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
CN109718209B
(zh)
*
|
2017-10-30 |
2021-03-05 |
浙江圣兆药物科技股份有限公司 |
一种低乙醇残留的利培酮微球冻干方法
|
CN109718212A
(zh)
*
|
2017-10-30 |
2019-05-07 |
浙江圣兆药物科技股份有限公司 |
一种减少利培酮微球中低挥发溶剂苯甲醇的方法
|
KR101862197B1
(ko)
*
|
2018-02-02 |
2018-05-29 |
이상운 |
빗물 고임 방지구조를 갖는 안내판 고정장치
|
CN111714442B
(zh)
*
|
2019-03-04 |
2024-04-12 |
广州铂思雅生物医药科技有限公司 |
植入剂的制备
|
GR1009870B
(el)
*
|
2019-07-09 |
2020-11-12 |
Φαρματεν Α.Β.Ε.Ε. |
Φαρμακευτικο σκευασμα που περιλαμβανει ενα ατυπο αντιψυχωσικο φαρμακο και μεθοδος παρασκευης αυτου
|
CN110407652B
(zh)
*
|
2019-08-19 |
2021-02-02 |
安徽雷鸣科化有限责任公司 |
一种水胶炸药的混装设备及其控制方法
|
CN113116830B
(zh)
*
|
2019-12-31 |
2024-07-02 |
广州铂思雅生物医药科技有限公司 |
缓释颗粒的制备
|
EP4125823A1
(en)
|
2020-03-30 |
2023-02-08 |
Biological E Limited |
Risperidone microspheres, process for their prepartion and uses thereof
|